Atherosclerosis and the vasuclar biology of aging

Aging Clinical and Experimental Research

Volumn 8, Issue 4, 1996, Pages 221-234

  Bilato, C ^a,b   Crow, M T ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Aging; Atherosclerosis; Endothelium; Smooth muscle cell; Vasculature

Indexed keywords

AGING; ATHEROSCLEROSIS; BIOLOGY; DISEASE SEVERITY; HUMAN; REVIEW; VASCULAR DISEASE; VASCULAR ENDOTHELIUM; ADULT; AGED; ANIMAL; ARTERIOSCLEROSIS; ARTERY; CELL DIVISION; FEMALE; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULAR SMOOTH MUSCLE;

ANIMALIA;

ADVANCED GLYCATION END PRODUCT; GROWTH PROMOTOR;

ADULT; AGED; AGING; ANIMALS; ARTERIES; ARTERIOSCLEROSIS; CELL DIVISION; ENDOTHELIUM, VASCULAR; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; GROWTH SUBSTANCES; HUMANS; MALE; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR;

EID: 0030203582     PISSN: 03949532     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (131)

1. National Center of Health Statistics. Vital statistics of the United States, 1989 Vol II Mortality Part A Washington, D C Government Printing Office. (DHHS publication n. (PHS), 93-1101, 1993
2. Corti M. C., Guralnik J. M., Bilato C. Coronary heart disease risk factors in older persons Aging Clin. Exp Res. 8 75-89, 1996
3. Kannel W.B., Gordon T.: Cardiovascular risk factors in the aged: the Framingham study. In. Haynes S.G., Feinleib M. (Eds.), Epidemiology of Aging NIH publication n. 80-969, 1980, pp 65-98.
4. Ross R.: The pathogenesis of atherosclerosis: a perspective for the 1990s Nature 362: 801-809, 1993.
5. Fuster V.: Mechanisms leading to myocardial infarction: insights from studies of vascular biology. Circulation 90: 2126-2146, 1994
6. Stary H.C., Blankenhom D.H., Chandler A.B., Glagou S., Insull W., Richardson M., Rosenfeld M.E., Schaffer S.A., Schwartz C.J., Wagner W.D., Wissler R.W.: A definition of intima of human arteries and of its atherosclerosis-prone regions. A report from the Committee on vascular lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 85: 391-405, 1992.
7. Stary H.C., Chandler A.B., Glagov S., Guyton J.R., Insull W., Rosenfeld M.E., Schaffer S.A., Schwartz C.J., Wagner W.D., Wissler R.W.: A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on vascular lesions of the Council on Arteriosclerosis. American Heart Association. Arterioscler. Thromb. 14: 840-856, 1994.
8. Stary H.C., Chandler A.B., Dinsmore R.E., Fuster V., Glagov S., Insull W., Rosenfeld M.E., Schwartz C.J., Wagner W.D., Wissler R.W.: A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on vascular lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler. Thromb. Vasc. Biol. 15: 1512-1531, 1995.
9. Ross R.: Cell biology of atherosclerosis. Ann. Rev. Physiol. 57: 791-804, 1995.
10. Faggiotto A., Ross R., Harker L.: Studies of hypercholesterolemia in the nonhuman primate. I. Changes that lead to fatty streak formation. Arteriosclerosis 4: 323-340, 1984.
11. Collins T.: Endothelial Nuclear Factor-κB and the initiation of the atherosclerotic lesion. Lab. Invest. 68: 499-507, 1993.
12. Iademarco M.F., McQuillan J.J., Rose J.D., Dean D.C.: Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1). J. Biol. Chem. 267: 16323-16329, 1992.
13. Degitz K., Lian-Jie L., Caughman S.W.: Cloning and characterization of 5′-transcriptional regulatory region of the human intercellular adhesion molecule 1 gene. J. Biol. Chem. 266: 14024-14030, 1991.
14. Collins T., Williams A., Johnston G.I., Kim J., Eddy R., Shows T., Gimbrone M.A. jr., Bevilacqua M.P.: Structure and chromosomal location of the gene for endothelial-leukocyte adhesion molecule 1. J. Biol. Chem. 266: 2466-2473, 1991.
15. Lin S.-J., Hong C.-Y., Chang M.-S., Chiang B.N., Chien S.: Long-term nicotine exposure increases aortic endothelial cell death and enhances transendothelial macromolecular transport in rats. Arterioscler. Thromb. 12: 1305-1312, 1992
16. Schwenke D.C., St Clair R.W.: Influx, efflux, and accumulation of LDL in normal arterial areas and atherosclerotic lesions of white Carneau pigeons with naturally occurring and cholesterol-aggravated aortic atherosclerosis. Arterioscler. Thromb 12: 1368-1381, 1993.
17. Nordestgaard B.G., Nielsen L.B.: Atherosclerosis and arterial influx of lipoproteins. Curr. Opin. Lipidol. 5: 252-257, 1994
18. Williams K.J., Tabas I.: The response-to-retention hypothesis of early atherogenasis. Arterioscler. Thromb. 15: 551-557, 1995.
19. Aqel N., Ball R., Waldmann H., Mitchinson M.: Monocytic origin of foam cells in human atherosclerotic plaques. Atherosclerosis 53: 265-271, 1984.
20. Stary H.C.: Evolution and progression of atherosclerotic lesions in children and young adults. Arteriosclerosis 99: 11-116, 1989.
21. Jawien A., Bowen-Pope D.F., Lindner V., Schwartz S.M., Clowes A.W.: Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J. Clin Invest. 89: 507-511, 1992
22. Casscells W.: Migration of smooth muscle and endothelial cells. Critical events in restenosis. Circulation 86: 723-729, 1992.
23. Jackson C.L., Raines E.W., Ross R., Reidy M.A.: Role of endogenous platelet-derived growth factor in arterial smooth muscle cell migration after balloon catheter injury. Arterioscler Thromb. 13: 1218-1226. 1993.
24. Schwartz S.M., Campbell G.R., Campbell J.H.: Replication of smooth muscle cells in vascular disease. Circ. Res. 58: 427-444, 1986.
25. Schwartz C.J., Valente A.J., Kelley J.L., Sprague E.A., Edwards E.H.: Thrombosis and the development of atherosclerosis: Rokitansky revisited. Semin. Thromb. Hemost. 14: 189-195, 1988.
26. Richardson P.D., Davies M.J., Born G.V.R.: Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques. Lancet 2: 941-944, 1989.
27. Henney A.M., Wakeley P.R., Davies M.J., Foster K., Hembry T., Murphy G., Humphries S.: Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc. Natl. Acad. Sci. USA 88: 8154-8158, 1991.
28. Moreno P.R., Falk E., Palacios I.F., Newell B.A., Fuster V., Fallon J.T.: Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture. Circulation 90: 775-778, 1994.
29. Van der Wal A., Becker A.E., van der Loos C.M., Das P.K.: Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of dominant plaque morphology. Circulation 89: 36-44, 1994.
30. Falk E.: Why do plaques rupture? Circulation 86: III30-III42, 1992.
31. Davies M.J., Thomas A.: Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. N. Engl. J. Med. 310: 1137-1140, 1984.
32. Caird F.I., Kennedy R.D.: Epidemiology of heart disease in older age. In: Caird F.I., Dall J.L.C., Kennedy R.D. (Eds.), Cardiology in old age. Plenum Press. New York, 1976, pp. 1-10.
33. Virmani R., Avolio A.P., Mergner W.J., Robinowitz M., Herderick E.E., Comhill J.F. Guo S.Y., Liu T.H., Ou D.Y., O'Rourke M.: Effect of aging on aortic morphology in populations with high and low prevalence of hypertension and atherosclerosis. Am J Pathol. 139: 1119-1129, 1991.
34. Spagnoli L.G., Orlandi A., Mauriello A., Santeusanio G., de Angelas C., Lucreziotti R., Ramacci M.T.: Aging and atherosclerosis in the rabbit 1. Distribution, prevalence and morphology of atherosclerotic lesions. Atherosclerosis 89: 11-24, 1991.
35. Weingand K.W., Clarkson T.B., Adams M.R., Bostrom A.D.: Effects of age and/or puberty on coronary artery atherosclerosis in cynomolgus monkeys. Atherosclerosis 62: 137-144, 1986.
36. Cooper L.T., Cooke J.P., Dzau V.J.: The vasculopathy of aging J. Gerontol 49: B191-B196, 1994.
37. Forneri C., Quaglino D., Mon G.: Role of the extracellular matrix in age-related modifications of the rat aorta Arterioscler. Thromb 12: 1008-1016, 1992.
38. Michel J.B., Heudes D., Michel O., Poitevin P., Philippe M., Scalbert E., Corman B., Levy B.I.: Effect of chronic angiotensin I converting enzyme inhibition on the aging processes: II. Large arteries. Am. J. Physiol. 267: R124-R135, 1994.
39. Spina M., Garbisa S., Hinnie J., Hunter J.C., Serafini-Fracassini A.: Age-related changes in composition and mechanical properties of the tunica media of the upper thoracic human aorta. Arteriosclerosis 3: 64-76, 1983.
40. Li Z., Miyashita Y., Cheng L., Lakatta E., Froehlich J., Remodeling of rat aortic wall during aging. FASEB J. 9: A606, 1995 (Abstract)
41. Toda T., Tsuda N., Nishimori I., Leszczynski D.E., Kummerow F.A.: Morphometric analysis of the aging process in human arteries and aorta. Acta Anat. 106: 35-44, 1980.
42. Benetos A., Laurent S., Hoeks A.P., Boutouyrie P.H., Safar M.E.: Arterial alterations with aging and high blood pressure. Arterioscler. Thromb. 13: 90-97, 1993.
43. Lakatta E.G.: Cardiovascular regulatory mechanisms in advanced age. Physiol Rev 73: 413-467, 1993.
44. Crow M.T., Boluyt M.O., Lakatta E.G.: Molecular and cellular aspects of cardiovascular aging. In. Holbrook N., Martin G.R., Lockshin R.A. (Eds.), Cellular Aging and Cell Death. Wiley-Liss Inc., New York, 1996, pp. 81-107.
45. Richardson M., Hatton M.W.C., Moore S.: Proteoglycan distribution in the intima and media of the aortas of young and aging rabbits: an ultrastructural study. Atherosclerosis 71: 243-256, 1988.
46. Cliff W.J.: The aortic tunica media in aging rats. Exp. Mol. Pathol. 13: 172-189, 1970.
47. Guyton J.R., Lindsay K.L., Dao D.T.: Comparison of aortic intima and inner media in young adult versus aging rats. Am. J Pathol. 111, 234-246, 1983.
48. Schlatmann J.M., Becker A.E.: Histologic changes in the normal aging aorta: implications for dissecting aortic aneurysm. Am. J. Cardiol. 39: 13-20, 1979.
49. O'Rourke M.F., Avolio A.P., Lauren P.D., Yong J., Age-related changes of elastin lamellae in the human thoracic aorta. J. Am. Coll. Cardiol 9: 53A, 1987 (Abstract).
50. Quaglino D., Fornieri C., Nanney L.B., Davidson J.M.: Extracellular matrix modifications in rat tissues of different ages. Matrix 13: 481-490, 1993.
51. Yamauchi M., Woodley D.T., Mechanic G.L.: Aging and cross-linking of skin collagen. Biochem. Biophys Res. Commun. 152: 898-903, 1988.
52. Robert L., Robert A.M.: Elastin, elastases, and arteriosclerosis. Front. Matrix Biol. 8, 130-173, 1980.
53. Hinek A., Mecham R.P., Keeley F.W., Rabinovitch M.: Impaired elastin fiber assembly related to reduced 67-κD elastin-binding protein in fetal lamb ductus arteriosus and in cultured aortic smooth muscle cells treated with chondroitin sulfate. J. Clin. Invest 88: 2083-2094, 1991
54. Robert L., Jacob M.P., Frances C., Godeau G., Hornebeck W.: Interaction between elastin and elastases and its role in the aging of the arterial wall, skin and other connective tissues. A review Mech. Ageing Dev. 28: 155-166, 1984
55. Gerrity R.G., Cliff W.J.: The aortic tunica intima in young and aging rats. Exp. Mol. Pathol 16: 382-402, 1972.
56. Haudenschild C.C., Forney Prescott M., Chobanian A.V.: Aortic endothelial and subendothelial cells in experimental hypertension and aging. Hypertension 3(1): 1148-1153, 1981.
57. Stein O., Eisemberg S., Stein Y.: Aging of aortic smooth muscle cells in rats and rabbits. Lab. Invest. 21: 386-397, 1969.
58. Rosenthal J.: Aging and the cardiovascular system. Gerontology 33(1): 3-8, 1987.
59. Pesonen E., Norio R., Hirvonen J., Karkola K., Kuusela V., Laaksonen H., Möttönen M., Nikkari T., Raekallio J., Viikari J., Ylä-Herttuala S., Akerblom H.K.: Intimal thickening in the coronary arteries of infants and children as an indicator of risk factor for coronary heart disease. Eur. Heart J. 11(E): 53-60, 1990.
60. Stary H.C., McMillan G.C.: Kinetics of cellular proliferation in experimental atherosclerosis: radioautography with grain counts in cholesterol-fed rabbits. Arch. Pathol. 89: 173-183, 1970.
61. Schwartz S.M., Heimark R.L., Majesky M.W.: Development mechanisms underlying pathology of arteries. Physiol. Rev. 70: 1177-1209, 1990.
62. Schwenke D.C., Carew T.E.: Quantification in vivo of increased LDL content and rate of LDL degradation in normal rabbit aorta occurring at sites susceptible to early atherosclerotic lesions. Circ. Res. 62: 699-710, 1989.
63. Spring P.M., Hoff H.F.: LDL accumulation in grossly normal human iliac bifurcation and common iliac arteries. Exp. Mol. Pathol. 51: 179-185, 1989.
64. Belmin J., Corman B., Merval R., Tedgui A.: Age-related changes in endothelial permeability and distribution volume of albumin in rat aorta. Am. J. Pathol. 33: H679-H685, 1993.
65. Hades D., Swindall B., Johnston J., Pamnani M., Haddy F.J.: Effects of ANP on venous pressure and microvascular protein permeability in dog forelimb. Am. J. Physiol. 259: H272-H279, 1989.
66. Vane J.R., Anggard E.E., Botting R.M.: Regulatory functions of the vascular endothelium, N. Engl. J Med. 323: 27-36, 1990.
67. Tokunaga O., Yamada T., Fan J., Watanabe T.: Age-related decline in prostacyclin synthesis by human aortic endothelial cells. Am. J. Pathol. 138: 941-949, 1991.
68. Miyata N., Tsuchida K., Okuyama S., Otomo S., Kamata K., Kasuya Y.: Age-related changes in endothelium-dependent relaxation in aorta from genetically diabetic WBN/Kob rats. Am J. Physiol 262: H1104-1109, 1992.
69. Atkinson J., Tatchum-Talom R., Corman B.: Effect of chronic ANG I-converting enzyme inhibition on aging processes. III. Endothelial function of mesenteric arterial bed of rat. Am. J. Physiol. 267: R136-R143, 1994.
70. Taddei S., Virdis A., Mattel P., Ghiadani L., German A., Basile Fasolo C., Sudano I., Salvetti A.: Aging and endothelial function in normotensive subjects and patient with essential hypertension. Circulation 91: 1981-1987, 1995.
71. Egashira K., Hirooka Y., Kai H., Sugimachi M., Suzuki S., Kuga T., Urabe Y., Takeshita A., Effects of age on endothelium-dependent vasodilatation of resistance coronary artery by acetylcholine in humans Circulation 88: 77-81, 1993.
72. Creager M.A., Cooke J.P., Mendelsohn M.E., Gallagher S.J., Coleman S.M., Loscalzo J., Dzau V.J.: Impaired vasodilatation of forearm resistance vessels in hypercholesterolemic humans. J. Clin. Invest. 86: 228-234, 1990.
73. Zeiher A.M., Drexler H., Wollschläger H., Just H.: Endothelial dysfunction of the coronary microvasculature is associated with impaired coronary blood flow regulation in patients with early atherogenesis. Circulation 84: 1984-1992, 1991.
74. Egashira K., Inou T., Hirooka Y., Yamada A., Maruoka Y., Kai H., Sugimachi M., Suzuki S., Takeshita A.: Impaired coronary blood flow response to acetylcholine in patients with coronary risk factors and proximal atherosclerosis lesions. J. Clin. Invest. 91: 29-37, 1993.
75. Treasure C.B., Klein J.L., Weintraub W.S., Talley J.D., Stillabower M.E., Kosinski A.S., Zhang J., Boccuzzi S.J., Cadarholm J.C., Alexander R.W.: Beneficial effects of cholesterol-lowering therapy on coronary endothelium in patients with coronary artery disease. N. Engl J Med. 332: 481-487, 1995
76. Andersen T.J., Meredith I.T., Yeung A.C., Frei B., Selwyn A.P., Ganz P.: The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N. Engl. J. Med. 332: 488-493, 1995.
77. Krejcy K., Schwarzacher S., Ferber W., PLesch C., Cybulsky M.I., Weidinger F.F.: Expression of VCAM-1 in rabbit iliac arteries is associated with vasodilator dysfunction of regenerated endothelium following balloon injury. Atherosclerosis 122: 59-67, 1996.
78. Luscher T.F., Tanner F.C., Dohi Y.: Age, hypertension and hypercholesterolemia alter endothelium-dependent vascular regulation. Pharmacol. Toxicol. 70: S32-S39, 1992.
79. Luscher T.F., Tanner F.C.: Endothelial regulation of vascular tone and growth. Am. J. Hypertens. 6: 283S-293S, 1993.
80. De Caterina R., Libby P., Peng H.-B., Thannickal V.J., Rajavashisth T.B., Gimbrone M.A., Shin W.S., Liao J.K.: Nitric oxide decreases cytokine-induced endothelial activation Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J. Clin Invest. 96: 60-68, 1995.
81. Peng H.-B., Libby P., Liao J.K.: Induction and stabilization of IκBα by nitric oxide mediates inhibition of NF-κB. J. Biol. Chem. 270: 14214-14219, 1995.
82. Kubes P., Suzuki M., Granger D.N.: Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc. Natl. Acad Sci. USA 88: 4651-4655, 1991.
83. Bath P.M.W.: The effect of nitric oxide-donating vasodilatators on monocyte chemotaxis and intracellular cGMP concentration in vitro. Eur J. Clin. Pharmacol. 45: 53-58, 1993.
84. Moncada S., Gryglewski R.J., Bunting S., Vane J.R.: An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 263: 663-665, 1976.
85. Radomski M.W., Palmer R.M., Moncada S.: An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc. Natl. Acad. Sci USA 87: 5193-5197, 1990.
86. Willis A.L., Smith D.L., Vigo C., Kluge A.F.: Effects of prostacyclin and orally active stable mimetic agent RS-93427-007 on basic mechanisms of atherogenesis. Lancet 2: 682-683, 1986
87. Garg U.C., Hassid A.: Nitric oxide generating vasodilatators and 8-bromocyclic guanosine monophosphare inhibit mitogenesis and proliferation on cultured rat vascular smooth muscle cells. J. Clin. Invest. 83: 1774-1777, 1989.
88. Sarkar R., Meinberg E.G., Stanley J.C., Gordon D., Webb R.C.: Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells. Circ. Res. 78: 225-230, 1996.
89. Dubey R.K., Jackson E.K., Lusher T.F.: Nitric oxide inhibits angiotensin II-induced migration of rat aortic smooth muscle cell Role of cyclic-nucleotides and angiotensin receptors. J. Clin. Invest. 96: 141-149, 1995.
90. Kolpakov V., Gordon D., Kulik T.J.: Nitric oxide-generating compounds inhibit total protein and collagen synthesis in cultured vascular smooth muscle cells. Circ. Res. 76: 305-309, 1995.
91. Cayatte A.J., Palacino J.J., Horten K., Cohen R.A.: Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits. Arterioscler. Thromb. 14: 753-759, 1994.
92. Cooke J.P., Singer A.H., Tsao P., Zera P., Rowan R.A., Billingham M.E.: Anti-atherogenic effects of L-arginine in the hypercholesterolemic rabbit. J. Clin. Invest. 90: 1168-1172, 1992
93. Lee J.S., Adrie C., Jacob H.J., Roberts J.D.jr., Zapol W.M., Bloch K.D.: Chronic inhalation of nitric oxide inhibits neointimal formation after balloon-induced arterial injury. Circ. Res. 78: 337-342, 1996.
94. Chang E., Harley C.B.: Telomere length and replicative aging in human vascular tissues. Proc. Natl. Acad. Sci. USA 92: 11190-11194, 1995.
95. Harley C.B., Futcher A.B., Greider C.W.: Telomeres shorten during ageing of human fibroblasts. Nature 345: 458-460, 1990.
96. Lundblad V., Szostack J.W.: A mutant with a defect in telomere elongation leads to senescence in yeast. Cell 57: 633-643, 1989.
97. Schwartz S.M., deBlois D., O'Brien E.R.M.: The intima. Soil for atherosclerosis and restenosis. Circ. Res. 77: 445-465, 1995.
98. Stemerman M.B., Weinstein R., Rowe J.W., Maciag T., Fuhro R., Gardner R.: Vascular smooth muscle cell growth kinetics in vivo in aged rats. Proc. Natl Acad. Sci. USA 79: 3863-3866, 1982
99. Hariri R.J., Hajjar D.P., Coletti D., Alonso D.R., Weksler M.E., Rabellino E.: Aging and arteriosclerosis. Cell cycle kinetics of young and old arterial smooth muscle cells. Am. J. Pathol. 131: 132-136, 1988.
100. McCaffrey T.A., Nicholson A.C., Szabo P.E., Weksler M.E., Weksler B.B.: Aging and arteriosclerosis. The increased proliferation of arterial smooth muscle cells isolated from old rats is associated with increased platelet-derived growth-like activity. J. Exp. Med. 167: 163-174, 1988.
101. Harin R.J., Alonso D.R., Hajjar D.P., Coletti P., Weskler M.E.: Aging and arteriosclerosis. 1. Development of myointimal hyperplasia after endothelial injury. J. Exp Med. 164: 1171-1178, 1986.
102. Sarzani R., Arnaldi G., Takasaki I., Brecher P., Chobanian A.V.: Effects of hypertension and aging on platelet-derived growth factor and platelet-derived growth factor receptor expression in rat aorta and heart. Hypertension 18: 93-99, 1991.
103. Miyagawa J., Higasbiyama S., Kawata S., Inui Y., Tamura S., Yamamoto K., Nishida M., Nakamura T., Yamashita S., Matsuzawa Y., Taniguchi N.: Localization of heparin-binding EGF-like growth factor in the smooth muscle cells and macrophages of human atherosclerotic plaques. J. Clin Invest. 95: 404-411, 1995
104. McCaffrey T.A., Falcone D.J.: Evidence for an age-related dysfunction in the antiproliferative response to transforming growth factor-β in vascular smooth muscle cells. Mol. Biol. Cell 4: 315-322, 1993
105. McCaffrey T.A., Falcone D.J., Brayton C.F., Agarwal L.A., Welt F.P., Weksler B.B.: Transforming growth factor-β activity is potentiated by heparin via dissociation of the transforming growth factor-β/α2 macroglobulin inactive complex. J. Cell Biol. 109: 773-781, 1992.
106. Bjorkerud S.: Effects of transforming growth factor-β1 on human arterial smooth muscle cells in vitro. Arteriosclerosis 11: 892-902, 1991.
107. 1 cell cycle arrest. J. Cell Physiol. 156: 48-55, 1993.
108. McCaffrey T.A., Consigli S., Du B., Falcone D.J., Sanbom T.A., Spokojny A.M., Bush H.L.jr.: Decreased type II/type I TGF-β receptor ratio an cells derived from human atherosclerotic lesions. J. Clin. Invest. 96: 2667-2675, 1995.
109. Kundra V., Escobedo J.A., Kazlauskas A., Kim H.K., Rhee S.A.G., Williams L.T., Zetter B.R.: Regulation of chemotaxis by platelet-derived growth factor receptor-β. Nature 367: 474-476, 1994.
110. Pauly R.R., Bilato C., Sollott S.J., Monticone R., Kelly P.T., Lakatta E.G., Crow M.T.: Role of calcium/calmodulin-dependent protein kinase II in the regulation of vascular muscle cell migration. Circulation 91: 1107-1115, 1995.
111. Lindner V., Lappi D.A., Baird A., Majack R.A., Reidy M.A.: Role of basic fibroblast growth factor in vascular lesion formation. Circ. Res. 68: 106-113, 1991.
112. Bilato C., Pauly R.R., Melillo G., Monticone R., Gorelick-Feldman D., Gluzband Y.A., Sollott S.J., Ziman B., Lakatta E.G., Crow M.T.: Intracellular signaling pathways required for rat vascular smooth muscle cell migration. Interactions between basic fibroblast growth factor and platelet-derived growth factor. J. Clin. Invest. 96: 1905-1915, 1995
113. Helin P., Garbarsch C., Helin G., Lorenzen I.: Vascular injury compared to ageing of the normal rabbit aorta. Blood Vessels 22: 94-104, 1985
114. Ylä-Herttuala S., Sumuvuori H., Karkola K., Motten M., Nikkari T.: Glycosaminoglycans in normal and atherosclerotic human coronary arteries. Lab. Invest. 54, 402-407, 1986
115. Ylä-Herttuala S., Nikkari T., Hirvonen J., Laaksonen H., Möttönen M., Pesonen E., Raekallio J., Åkerblom H.K.: Biochemical composition of coronary arteries in Finnish children. Arteriosclerosis 6: 230-236, 1986.
116. Salisbury B.G.J., Falcone C.J., Minick C.R.: Insoluble low-density lipoprotein-proteoglycan complexes enhances cholesterol ester accumulation in macrophages. Am. J Pathol 120: 6-11, 1985.
117. Woods A., Couchman J.R.: Focal adhesions and cell-matrix interactions. Collagen Rel. Res. 8: 155-182, 1988
118. Kinsella M.G., Wight T.N.: Modulation of sulfated proteoglycan synthesis by bovine aortic endothelial cells during migration. J Cell Biol 102: 679-687, 1986
119. Robert L., Jacob M.P., Labat-Robert J.: Cell-matrix interaction in the genesis of arteriosclerosis and atheroma: effect of aging. Ann. N. Y. Acad. Sci. 673: 331-341, 1992.
120. Reiser K. M.: Non enzymatic glycation of collagen in aging and diabetes. Proc. Soc. Exp. Biol. Med. 196: 17-29, 1991.
121. MacDonald E., Lee W.K., Hepbum S., Bell J., Scott P.J.W., Dominiczak M.H.: Advanced glycation end products in the mesenteric artery. Clin. Chem. 38: 530-533, 1992.
122. Brownlee M., Cerami A., Vlassara H.: Advanced glycation end products in tissue and the biochemical basis of diabetic complications. N. Engl. J Med. 307: 205-211, 1988.
123. Neeper M., Schimdt A.-M., Brett J., Van S.-D., Wang F., Pan Y. C., Elliston K., Stern D., Shaw A.: Cloning and expression of RAGE: a cell surface receptor for advanced glycation end products of proteins. J Biol. Chem. 267: 14998-15004, 1992.
124. Schimdt A.-M., Hori O., Brett J., Yan S.-D., Wautier J.-L., Stern D.: Cellular receptor for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. Arterioscler. Thromb. 14: 1521-1528, 1994.
125. Brett J., Schimdt A.-M., Yan S.-D., Zou Y.-S., Weidman E., Pinsky D., Nowygrod R., Neeper M., Przysiecki C., Shaw A., Migheli A., Stern D.: Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. Am. J. Pathol. 143: 1699-1712, 1993.
126. Vlassara H., Fuh H., Cybulsky M.: Adhesion molecules and atheroma in rabbits injected with advanced glycation products. Circulation 90: I-84, 1994 (Abstract).
127. Yan S.-D., Schmidt A.-M., Anderson G.M., Zhang J.H., Brett J., Zou Y.-S., Pinsky D., Stern D.: Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptor/binding protein. J. Biol. Chem. 269: 9889-9897, 1994.
128. Schmidt A.-M., Hori O., Chen J.X., Li J.F., Crandall J., Zhang J., Cao R., Yan S.-D., Brett J., Stern D.: Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cell and in mice. a potential mechanism for accelerated vasculopathy of diabetes. J. Clin. Invest. 96: 1395-1403, 1995.
129. Fredman J., Pauly R.R., Stern D., Schmidt A.-M., Yan S.-D., Brett J., Monticone R., Crow M.T.: Advanced glycation end products interacting with their receptors activate vascular smooth muscle cells: induction of chemoattractants for smooth muscle cells and monocytes. Circulation 90: 1-121, 1994 (Abstract).
130. Schmidt A.-M., Yan S.-D., Brett J., Mora R., Nowygrod R., Stern D.: Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products. J. Clin. Invest 92: 2155-2168, 1993
131. Kirstein M., Brett J., Radoff S., Ogawa S., Stern D., Vlassara H.: Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor, role in vascular disease of diabetes and aging. Proc. Natl. Acad. Sci. USA 87: 9010-9014, 1990